E N D
1. Oncology I Basic Science Conference
April 21, 2005
Jason Frischer
2. Question 1 A 45-year-old man has early satiety and epigastric pain. The abdominal CT shown is obtained. Biopsy shows the accompanying histology and immunohistochemical staining shows the tumor to be c-kit positive.
Which of the following statements about this tumor is true?
These tumors metastasize early to the lung
They are often responsive to doxorubicin
Surgical resection offers at least a 75% chance of a cure
RT improves disease-free interval after resection
Recurrent tumor after resection would likely respond to STI-571 (Gleevec)
5. GIST Previously classified as a leiomyosarcoma
Arise from the interstitial cells of Cajal, an intestinal pace maker
These cells stain for CD-34 and possess the c-Kit protooncogene
Imatinib or Gleevec is a tyrosine kinase receptor inhibitor in tumors that contain c-KIT mutations
6. GIST
7. GIST Surgical resection offers a 50% cure rate
Chemo and RT do not work
Recurrence is local
Follow patients with PET scans
9. Question 2 Which of the following patients is LEAST likely to benefit from a LN dissection?
45-year-old man with an 80 pack-year smoking history with non small cell carcinoma of the lung and mediastinal nodes
55-year-old male fishing capt. With a 2mm melanoma on the shoulder with palpable nodes in the axilla
32-year-old woman with papillary thyroid cancer and palpable nodes in the neck
48-year-old woman with 1.5 cm invasive ductal carcinoma of the breast with palpable nodes in the axilla
31-year-old man with biopsy confirmed prepyloric 1cm gastric adenocarcinoma
11. Lymph Node Dissection Depends on the type of tumor and extent of local disease (presence of nodes)
NSCLC offers no advantage from lymphadenectomy after staging is completed
A pt. with melanoma and LNs should have a dissection (Sentinel LN)
Thyroid cancer pts should have a lymph node dissection only if palpable nodes are detected. Prophylactic dissectin is not indicated
Palpable nodes in Breast Ca warrant LN dissection
12. Lymph Node Dissection Prognostic Factors in Breast Ca
Tumor size -lymph/vessel invasion
High grade -ER/PR status
HER-2-neu -DNA ploidy
Cell synthesis phase
Lymph node status best predictor
Resectable gastric cancer should have a LN dissection (D1 vs D2)
13. Question 3 A 29-year-old man has a 3-cm non-keratinizing squamous cell carcinoma of the anal canal without inguinal adenopathy. The pt. is HIV + and has a CD4 count of 508 cells/mcl. Which of the following statements is TRUE?
The pt. has clinical AIDS
Non-karatinizing squamous cell carcinoma of the anal canal has a better prognosis than keratinizing squamous cell carcinoma
This lesion is likely to have originated at or above the dentate line
With appropriate treatment the likelihood for cure is greater than 90%
This lesion is best treated with local excision and wound closure with local advancement or rotational flaps
15. Anal Cancer Association between HIV and anal cancer (HPV)
Unlike KS, anal cancer is not an indicator of HIV progression
Keratinizing and non-keratinizing squamous cell carcinoma of the anal canal are similar in both biology and prognosis
Non-keratinizing SCC often originates from above the dentate line
16. Anal Cancer Size is the most important prognostic factor
Tumors < 2cm have an 80% long term survival
Increased mets with tumors > 2 cm
Treatment is chemo/RT (Nigro protocol)
APR for persistent or recurrent disease
Local excision is not indicated
17. Question 4 63 year-old man has a LAR for rectal cancer. Staging is T3 N0 M0 adenocarcinoma. Them most appropriate postoperative treatment would be
Close follow up
Adjuvant chemo with 5-FU and leukovorin
Adjuvant chemo with 5-FU and irinotecan
Adjuvant radiotherapy
Adjuvant chemoradiotherapy
20. Rectal Cancer This pt. has stage II carcinoma of the rectum.
Stage II and III are at high risk for local and distant recurrence
Treatment includes chemo with 5-FU and leukovorin plus RT
Reduces recurrence rate by 34%
21. Question 5 Genetic testing in patients with familial adenomatous polyposis (FAP)
Can identify those with invasiva carcinoma
Confirms the K-ras oncogene as the key genetic marker
Has identified the adenomatous polyposis coli (APC) tumor suppressor gene as the causative entity
Has identified FAP as part of the Lynch syndrome
Is associated with a rate of 30% to 70% penetrance
23. Genetics 2 categories of genes associated with colon cancer
Oncogenes
Protooncogenes are activated into oncogenes
Initiate alterations in cell structure or function
K-ras, S-ARC, and TRK
Suppressor genes
Found in the genotype of a normal cell
Alterations occur when these genes are inactivated
P53 (most common mutation in colon cancer) and APC
24. Genetics 20% of new cases of colon cancer involve hereditary changes
FAP is involved in < 1% of colon cancers
Result of mutation in the tumor suppressor gene APC (90% penetrance)
HNPCC (Hereditary NonPolyposis Colon Cancer)
1-3% of colon cancers
30 – 70% penetrance
Part of Lynch Syndrome
25. Genetics Familial Colon Cancer (FCC)
Accounts for 20% of colon cancers
No genetic markers
26. Question 6 2 years after an AAA repair, a 76 year-old man has an obstructing colon stricture. At left colectomy, abdominal exploration reveals the lesion pictured here in the mid jejunum. Biopsy confirms carcinoid. Which of the following statements is NOT true?
50% of carcinoid tumors are found in the appendix
Carcinoid has variable malignant potential
The cell of origin is the Kulchitsky cell
Treatment includes wide segmental resection
Tumors are rarely multicentric
28. Carcinoid Most frequent small bowel neoplasm
Arise from Kulchitsky cell
As enterochromaffin or argentaffin
Located in the crypts of Lieberkuhn
Half are located in the appendix
Characteristic yellow, tan, or gray appearance
29. Carcinoid Generally follow an indolent course
May cause ulceration, bleeding, or obstruction
30% are multicentric
Tumor size is predictive of metastasis
< 1 cm rarely metastasize
Treated with wide segmental resection
30. Question 7 56 year-old woman has a left temple lesion as shown. Excisional biopsy shows a melanoma, Clark’s level III and Breslow depth 1.1 mm. Initial management should consist of wide local excision and
Interferon alpha-2b
Sentinel node biopsy
Adjuvant chemotherapy
Radical neck dissection
parotidectomy
32. Melanoma Presence of nodes is the most important prognostic indicators and dictates therapy
Node dissection for a lesion between 0.75 to 2.5 mm is controversial in the absence of clinically palpable LNs.
33. Question 8 A 45 year-old man who has been HIV + for 15 years has a painful 3-cm neck mass. A 2-week course of antibiotics does not change the mass. Biopsy will most likely reveal
Hodgkin’s lymphoma
B cell lymphoma
T cell lymphoma
Metastatic lung carcinoma
Kaposi’s sarcoma
35. HIV and Cancer Increase in Kaposi’s sarcoma, skin cancers, cervical cancer, and most commonly non-Hodgkin’s lymphoma
Increased 150 – 250 fold
Lymphadenopathy in this pt. population should be regarded as lymphoma until proven otherwise
36. Question 9 A 60 year-old asymptomatic man with a family history of colon cancer seeks advice on personal screening for colon cancer. The recommended screening test for colon cancer in this patient is
Serial fecal occult blood tests
Flexible sigmoidoscopy
Virtual colography
Colonoscopy
Barium enema
38. Colon Cancer Screening Full colonoscopy is now the current recommendation for all pt. > 50
39. Question 10 55 year-old woman with a history of chronic indigestion has a heme positive stool test. Colonoscopy is negative. EGD shows a 10 cm submucosal mass in the midportion of the stomach on the greater curvature. Biopsies are negative. Wedge resection is performed. Which of the following statements is TRUE?
Approximately 25% of these lesions are malignant
The extent of resection affects long-term survival
Fundic lesions are more likely to be benign
Tumor behavior cannot be predicted from histological grade
These lesions arise from smooth muscle in the gastric wall
41. GIST GIST are most often found in the stomach
Originate from stromal rather than epithelial or smooth muscle elements
In the stomach, bleeding is characteristic
Substantial malignant potential
Tumor size and # of mitoses/hpf are the best predictors of malignant potential
75% of the tumors arising from the fundus are malignant
42. Question 11 The tumor suppressor gene that predicts whether Barrett’s esophagus will progress to esophageal cancer is
bcl-2
Ki-67
p53
APC
H-ras
44. p53 Tumor suppressor gene
If mutated, removes its suppressor effects
Over expression of p53 is seen in pts. With high grade dysplasia who subsequently develop cancer
It is NOT clear if a pt. with HGD and shows no expression of p53 can safely be observed rather than undergo resection or ablation
45. Question 12 Which of the following genetic factors directly affects apoptosis in breast cancer?
P53
Bcl-2
HER2
BRCA
PEG-3
47. Genetics and Breast Cancer p53 gene produces a protein that prevents propagation of cells with abnormal DNA
bcl-2 suppresses cell death
bcl-2 is anti-apoptotic (bad)
p53 down regulates bcl-2 in cells with abnormal DNA, thus triggering apoptosis
HER2 is a tyrosine kinase (cell growth)
HER2 overexpression occurs in DCIS and in more malignant tumors
48. Genetics and Breast Cancer Epidermal growth factors (EGF) are known to be elevated in breast cancer
Involved in vessel permeability and promotes invasiveness
Progression elevated gen-3 (PEG-3) seems to be associated with tumor progression
BRCA1 and 2 predispose to breast cancer
49. Question 13 Patients who are at high-risk for developing distal esophageal adenocarcinoma may have all of the following characteristics EXCEPT
Onset of reflux symptoms at an early age
Severe nocturnal reflux symptoms
Elderly white male smokers
Presence of intestinal metaplasia in the gastric cardia
Loss of p53 gene heterogeneity on chromosome 17
51. Esophageal Cancer Distal esophageal cancer is strongly associated with chronic gastroesophageal reflux.
Replacement of normal stratified squamous epithelium with columnar epithelium
All pts. with Barret’s esophagus are at increased risk for developing adenocarcinoma, a subset are at increased risk:
Elderly white make smokers with esophagitis, ulceration, stricture, and bleeding
Intestinal metaplasia often due to H. pylori are at a significantly lower risk of progressing to adenocarcinoma than pts. with Barrett’s.
The metaplasia may regress with appropriate medical therapy
52. Question 14 52 year-old woman has vague abdominal pain associated with eating. An ultrasound study of the right upper quadrant demonstrates a 12-mm sessile polyp in the gallbladder. There is no evidence of gallstones or wall thickening. The next step in management should be
Observation
Evaluation for familial polyposis
Follow-up ultrasound every 6 months
Laparoscopic cholecystectomy
Open cholecystectomy
54. Gallbladder Polyps Incidence is ~5% on ultrasound
˝ due to cholesterolosis
< 1 cm
Multiple - if multiple are seen then likely due to cholesterolosis
Follow up ultrasounds 3 – 6 months
Pedunculated polyps tend to be benign
Sessile have the propensity to be malignant
55. Gallbladder Polyps Open cholecystectomy is indicated when there are fewer than 3 polyps, for those larger then 1 cm, and for sessile polyps or those that show signs of eroded mucosa.
Open cholecystectomy is preferred over laparoscopic to avoid inadvertent spillage
Gallbladder cancer has tendency for peritoneal and port site seeding
56. Question 15 Which of the following statements about sentinel lymph node (SLN) biopsy for melanoma is NOT true?
Combining radiolymphoscintigraphy and intraoperative blue dye injection increases accuracy
Radiolymphoscintigraphy is performed with Tc-99
The false-negative rate is higher for melanoma of the head and neck than for extremity melanoma
SLN biopsy is associated with an overall survival benefit
SLN biopsy is not useful after previous local excision of a melanoma
58. Sentinel Lymph Node Incidence of melanoma is increasing in the US
LN dissection is indicated in pts. with 1 to 2 mm thick melanomas and pts. over 60
Blue dye increases the success rate of SLN biopsies
SLN biopsy does NOT affect survival
Identifies the patients with occult mets and therefore allows you to give more aggressive treatments
59. Question 16 A healthy 57 year old man has a 1.8 cm invasive adenocarcinoma of the anterior wall of the rectum, 2 cm from the dentate line. On rectal exam the lesion is hard, discrete, and ulcerated. CT scan is normal. Endorectal ultrasound shows extension into the muscularis propria. Recommended management would be
Proctocolectomy and J pouch
Transanal local excision with adjuvant chemo/RT
APR
RT
Parasacral (Kraske) resection
61. Colorectal Cancer
62. Colorectal Cancer APR has survival rates of:
87% for T3 N0
68% for T3 N1-2
64% for Tany N1-2
Minimum of 2 cm distal to the tumor is required for adequate margins
6 cm suggested for poorly differentiated lesions
LAR acceptable for lesions in the upper 1/3 of rectum
Middle and distal 1/3s possible LAR
63. Question 17 Which of the following statements about preoperative neoadjuvant chemo- and radiation therapy for rectal carcinoma is TRUE?
This treatment decreases the # of pts. requiring APR
Perineal healing is unaffected if APR is performed
Anastomotic leak rates are increased if a LAR is performed
Patients with T2 lesions benefit from this treatment
Local recurrence rates are not improved overall
65. Neoadjuvant therapy Inconclusive data
Significant # of pts. can be clinically downstaged
Allows for the avoidance of proctectomy
Cure rates have not improved BUT local recurrence rates are reduced
Does not affect leak rate in LAR
Does cause problems with healing an APR
66. Question 18 Which of the following statements about sentinel lymph node biopsy in malignant melanoma is TRUE?
It should be done for all lesions regardless of depth
It is positive in 5% to 10% of thin (< 0.76 mm) melanomas
For lesions < 4 mm in depth, it should be performed to determine the need for completion lymphadenectomy
Skip metastases can occur in 15% to 20% of cases
Completion lymphadenectomy after a positive sentinel lymph node biopsy will show no further evidence of malignancy in > 90 % of cases
68. Melanoma Melanomas < 0.76 mm in thickness are generally not considered for sentinel lymph node biopsy because the long-term survival after local excision alone is excellent
SLN bx not warranted for lesions > 4mm
Useful for intermediate depth
For + SLN, completion lymphadenectomy will show further LN metastases in ~ 8%